Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism ACKR3 inhibitors(atypical chemokine receptor 3 inhibitors), CXCR3 antagonists(C-X-C motif chemokine receptor 3 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Preclinical | US | 30 Jan 2022 | |
Solid tumor | Preclinical | US | 30 Jan 2022 |